Anxiety, Stress and Pain & Myocardial Infarction

Recruiting

• Conditions: Myocardial Infarction
• Interventions: Other: No intervention

• Registration Number: NCT04130269
• Lead Sponsor: Medical University of Graz

Brief Summary

People often experience the acute phase of a myocardial infarction as a stressful and traumatic event that seems lifethreatening. Such anxiety, pain and stress can lead to the development of posttraumatic stress disorder in the long run. Previous studies suggest that there might be a relevant percentage of people developing Posttraumatic Stress Disorder (PTSD) after a myocardial infarction. Posttraumatic stress disorder is a risk factor for the development of coronary heart disease. The goal of this study is to detect the percentage of people that develop symptoms of anxiety, stress, and PTSD after an acute myocardial infarction.

Detailed Description

People often experience the acute phase of a myocardial infarction as a stressful and traumatic event that seems lifethreatening. Such anxiety, pain and stress can lead to the development of posttraumatic stress disorder in the long run. Previous studies suggest that there might be a relevant percentage of people developing PTSD after a myocardial infarction. Posttraumatic stress disorder is a risk factor for the development of coronary heart disease. The goal of this study is to detect the percentage of people that develop symptoms of anxiety, stress and PTSD after an acute myocardial infarction.

Patients will be examined during three times - in the acute myocardial infarction period (Day 1-3), before dismissal (Day 5-14) and after 6 months for a follow-up. During all times they will be given questionnaires asking about their levels of stress, anxiety and general well-being as well as tests checking their cognitive abilities (thus to find out if they decrease over time). Moreover, blood samples checking cortisol levels as well as metanephrine levels will be taken in order to objectify the levels of stress that are stated by the patients. Furthermore, clinical evaluations, laboratory runs (troponin), ECGs and echocardiographies will be done at all three points in time.

The goal is to detect the biopsychosocial relations and to develop better prevention.

Study Timeline

• Study First Submitted: 2019-10-16
• Study First Submitted QC: 2019-10-16
• Study First Posted: 2019-10-17
• Study Start: 2020-04-07
• Status Verified: 2023-01
• Last Update Submitted: 2023-01-10
• Last Update Posted: 2023-01-11
• Primary Completion: 2024-12-07
• Study Completion: 2024-12-07

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

• willingness to participate in the study
• men and women 19-90
• after myocardial infarctions
• no psychiatric disease before myocardial infarction
• no other severe disease influencing the immune system

Exclusion Criteria

• non fulfilment of inclusion criteria
• non-compliant patients (dementia, delirium)
• steroid-therapy

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Patients with MCI	No intervention	Patients with myocardial infarction (STEMI/NSTEMI) aged 19-90

Primary Outcome Measures

Name	Time	Method
PTSD	6 months	Number of patients who develop PTSD

Trial Locations

Locations (1)

Medical University of Graz; 🇦🇹 Graz, Styria, Austria